# The Efficacy of the Whisperflow CPAP System Versus Nasal High Flow in Patients at High Risk for Postextubation Failure

> **NCT02918786** · NA · UNKNOWN · sponsor: **Ramathibodi Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Respiratory Failure

## Interventions

- **DEVICE:** Nasal high-flow
- **DEVICE:** CPAP

## Key facts

- **NCT ID:** NCT02918786
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2016-11
- **Final completion:** 2017-03
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918786, "The Efficacy of the Whisperflow CPAP System Versus Nasal High Flow in Patients at High Risk for Postextubation Failure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02918786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*